A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up

Table 1

Characteristics of patients.

	Dulaglutide	Glimepiride
Cases ()	13	10
Male/female ()	7/6	6/4	0.768
Age (years)			0.575
Diabetes history (years)	2.0 (0.5, 9.0)	2.0 (1.0, 3.5)	0.851
Body weight (g)			0.948
BMI (kg/m^2)			0.466
Systolic blood pressure (mmHg)			0.865
FBG (mmol/L)			0.09
HbA1c (%)			0.25
Cholesterol (mmol/L)			0.008
HDL cholesterol (mmol/L)			0.181
LDL cholesterol (mmol/L)			0.089
Triglycerides (mmol/L)			0.031
Hemoglobin (g/L)			0.379
Urea nitrogen (mmol/L)			0.156
Creatinine (μmol/L)			0.641
AST (U/L)			0.323
Uric acid (μmol/L)			0.844
GFR (mL/min)			0.093

BMI: body mass index; FBG: fasting blood glucose; HbA1c: glycosylated hemoglobin; HDL: high-density lipoprotein; LDL: low-density lipoprotein; AST: aspartate transaminase; GFR: glomerular filtration rate. Data shown as or median (first quartile, third quartile). Dulaglutide vs. glimepiride: .